Idiopathic intracranial hypertension (IIH) has a highly variable clinical presentation and outcome, making the management and follow-up of an individual patient a challenge for both neurologists and ophthalmologists. Because a number of patients irreversibly lose vision or have a chronic disease with reduced quality of life, the term 'benign intracranial hypertension' is not used anymore.
Date
2013-02-13
Language
eng
Format
video/mp4
Type
Image/MovingImage
Source
2013 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of
NANOS 2013: Update on the Management of Idiopathic Intracranial Hypertension
